Merck narrows full-year sales guidance
Go back to Merck narrows full-year sales guidance| Merck & Co. (NYSE: MRK) | Delayed: 156.45 +5.79 (3.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.66 | 52 Week High | $65.46 | |||
| Open | $151.00 | 52 Week Low | $47.97 | |||
| Day High | $156.92 | P/E | 106.43 | |||
| Day Low | $150.66 | EPS | $1.47 | |||
| Volume | 13,898,400 | |||||

